Visualization of naturally occurring Foxp3+ regulatory T cells in normal and tumor-bearing mice

被引:38
|
作者
Hontsu, S
Yoneyama, H
Ueha, S
Terashima, Y
Kitabatake, M
Nakano, A
Ito, T
Kimura, H
Matsushima, K
机构
[1] Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan
[2] Nara Med Univ, Dept Internal Med 2, Nara 6348522, Japan
关键词
T lymphocytes; transcription factors; tumor immunity; spleen; lymph nodes;
D O I
10.1016/j.intimp.2004.07.026
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD25+CD4+ regulatory T cells (Treg) play pivotal roles in the host response to tumors. However, their exact location in vivo is largely unknown. The forkhead/winged helix transcription factor, Foxp3, is specifically expressed in naturally occurring Treg (nTreg) and programs their development and function. In this study, we produced a rabbit polyclonal antibody (pAb), which can detect mouse Foxp3 protein in situ. Results using this pAb revealed that Foxp3+CD4+ nTreg cells occur in direct contact with CD11c+ dendritic cells (DCs), and Foxp3-CD4+ and CD8+T lymphocytes in the T cell regions of lymphoid tissues from normal and tumor-bearing mice. The numbers of Foxp3+CD4+ nTreg cells are significantly increased in draining, but not nondraining, lymph nodes (LNs) and spleen (SPL) of tumor-bearing mice. Furthermore, a small number of nTreg could be also found at the tumor site. These observations support the notion that the numbers of Foxp3+CD4+ nTreg are increased by tumors and may contribute to the immunosuppression observed in tumor-bearing hosts at secondary lymphoid organs and also possibly at the turnor site. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:1785 / 1793
页数:9
相关论文
共 50 条
  • [31] Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity
    Xiao-wen Zhu
    Hai-zhen Zhu
    You-qing Zhu
    Mao-hui Feng
    Jian Qi
    Zhi-fen Chen
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2016, 36 : 677 - 682
  • [32] Foxp3 Expression in CD4+CD25+Foxp3+ Regulatory T Cells Promotes Development of Colorectal Cancer by Inhibiting Tumor Immunity
    朱晓文
    朱海珍
    朱尤庆
    冯茂辉
    齐健
    陈志芬
    Current Medical Science, 2016, 36 (05) : 677 - 682
  • [33] Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine
    Kao, John Y.
    Zhang, Min
    Chen, Chuan-Min
    Pierzchala, Anna
    Chen, Jian-Jun
    IMMUNOLOGY LETTERS, 2006, 105 (01) : 16 - 25
  • [34] Human T-Lymphotropic Virus Type 1-Induced CC Chemokine Ligand 22 Maintains a High Frequency of Functional FoxP3+ Regulatory T Cells
    Toulza, Frederic
    Nosaka, Kisato
    Tanaka, Yuetsu
    Schioppa, Tiziana
    Balkwill, Frances
    Taylor, Graham P.
    Bangham, Charles R. M.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (01) : 183 - 189
  • [35] OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity
    Kitamura, Naomi
    Murata, Satoshi
    Ueki, Tomoyuki
    Mekata, Eiji
    Reilly, R. Todd
    Jaffee, Elizabeth M.
    Tani, Tohru
    INTERNATIONAL JOURNAL OF CANCER, 2009, 125 (03) : 630 - 638
  • [36] Identification and Clinical Relevance of Naturally Occurring Human CD8+HLA-DR+ Regulatory T Cells
    Arruvito, Lourdes
    Payaslian, Florencia
    Baz, Placida
    Podhorzer, Ariel
    Billordo, Ariel
    Pandolfi, Julieta
    Semeniuk, Guillermo
    Arribalzaga, Eduardo
    Fainboim, Leonardo
    JOURNAL OF IMMUNOLOGY, 2014, 193 (09) : 4469 - 4476
  • [37] A distribution study of C-11 platelet-activating factor (PAF) analogs in normal and tumor-bearing mice
    Sasaki, T
    Tohyama, T
    Oda, K
    Toyama, H
    Ishii, SI
    Senda, M
    Karasawa, K
    Satoh, N
    Setaka, M
    Nojima, S
    Nozaki, T
    Braquet, P
    NUCLEAR MEDICINE AND BIOLOGY, 1996, 23 (03) : 309 - 314
  • [38] CIRP increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TLR4-IL-2 signaling in the late phase of sepsis
    Wu, Zongsheng
    Liu, Xu
    Huang, Wei
    Chen, Jing
    Li, Songli
    Chao, Jie
    Xie, Jianfeng
    Liu, Ling
    Yang, Yi
    Wu, Xiaojing
    Qiu, Haibo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 132
  • [39] Prophylactic DNA vaccine targeting Foxp3+ regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model
    Namdar, Afshin
    Mirzaei, Reza
    Memarnejadian, Arash
    Boghosian, Roobina
    Samadi, Morteza
    Mirzaei, Hamid Reza
    Farajifard, Hamid
    Zavar, Mehdi
    Azadmanesh, Kayhan
    Elahi, Shokrollah
    Noorbakhsh, Farshid
    Rezaei, Abbas
    Hadjati, Jamshid
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (03) : 367 - 379
  • [40] Phototheranostics of Splenic Myeloid-Derived Suppressor Cells and Its Impact on Spleen Metabolism in Tumor-Bearing Mice
    Barnett, James D.
    Jin, Jiefu
    Penet, Marie-France
    Kobayashi, Hisataka
    Bhujwalla, Zaver M.
    CANCERS, 2022, 14 (15)